Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma
- 1 November 2015
- journal article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 138, 37-44
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Awake craniotomy for gliomas in a high-field intraoperative magnetic resonance imaging suite: analysis of 42 casesJournal of Neurosurgery, 2014
- Immunohistochemical and molecular genetics study of a granular cell astrocytoma: A case report of malignant transformation to a glioblastomaNeuropathology, 2012
- Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling indexRadiation Oncology, 2012
- Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomasThe Lancet Oncology, 2011
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in GliomaThe Journal of Molecular Diagnostics, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial GliomasJournal of Neuropathology & Experimental Neurology, 2005
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000